Navigation Links
Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
Date:5/9/2013

ircumstances after the issuance of this press release.

[Financial tables follow]SEQUENOM, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)(In thousands, except per share information)Three Months Ended March 31,20132012Revenues:Diagnostic services

$

29,083$

4,780Genetic analysis product sales and services

9,41510,140Total revenues

38,49814,920Cost of revenues:Cost of diagnostic services

21,0796,871Cost of genetic analysis product sales and services

3,4593,423Total cost of revenues

24,53810,294Gross margin

13,9604,626Operating expenses:Selling and marketing

13,6579,677Research and development

13,83411,844General and administrative

13,4837,350Total operating expenses

40,97428,871Loss from operations

(27,014)(24,245)Other income (expense), net

(2,334)(176)Loss before income taxes

(29,348)(24,421)Income tax expense

(12)(2)Net loss

$

(29,360)$

(24,423)Net loss per common share, basic and diluted

$

(0.26)$

(0.22)Weighted average number of shares outstanding, basic and diluted

115,040110,512 

 SEQUENOM, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)(In thousands)March 31,
2013December 31,
2012AssetsCurrent assets:Cash, cash equivalents and marketable securities

$

151,075$

175,942Accounts receivable, net

7,1277,887Inventories

12,58210,570Other current assets and prepaid expenses

3,6393,075Total current assets

174,423197,474Property, equipment and leasehold improvements, net

35,24333,494Other assets

18,32517,987Total assets

$

227,991$

248,955Liabilities and stockholders' equityCurrent liabilities:Accounts payable

$

20,479$

16,469Accrued expenses

2
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
2. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
3. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
4. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
5. Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
7. Chindex International, Inc. Reports First Quarter 2013 Financial Results
8. BioScrip Reports First Quarter 2013 Financial Results
9. China Biologic Reports Financial Results for the First Quarter of 2013
10. Nephros Reports First Quarter 2013 Financial Results
11. PharmAthene Reports First Quarter 2013 Financial And Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015 About cardiovascular implants ... narrowing or blockage of blood vessels. Cardiac disease ... high cholesterol, and high blood pressure. Coronary artery ... heart failure are some of the major cardiac ... especially coronary arteries, is one of the most ...
(Date:9/3/2015)... , Sept. 3, 2015 About dry eye syndrome ... eyes due to deficient tear production or quick tear ... of two types: aqueous tear deficient dry eye and ... lacrimal glands do not produce enough tears, whereas meibomian ... secrete lipids to slow tear evaporation and maintain tear ...
(Date:9/3/2015)... 2015  WellCare Health Plans, Inc. (NYSE: WCG ... vice president and chief financial officer, is scheduled to ... on Wednesday, September 9, 2015, at 9:25 a.m. Eastern ... In addition, a replay of the webcast will be ... the live broadcast and the replay will be available ...
Breaking Medicine Technology:Global Cardiovascular Implants Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2
... 2012 QRxPharma (ASX: QRX and OTCQX: QRXPY) announced ... healthy volunteers for MoxDuo® CR, a controlled-release Dual-Opioid® utilising ... MoxDuo CR formulation, encompassing both sustained delivery technology as ... designed to provide at least 12 hours of analgesia ...
... ® and Lung Cancer Alliance hailed the ... conducted by Milliman Inc., an internationally recognized actuarial ... olds at high risk for lung cancer with ... lives, and at lower cost than commonly used screening ...
Cached Medicine Technology:QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 2QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 3QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 4Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective 2Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective 3
(Date:9/3/2015)... ... September 03, 2015 , ... NanoCytomics LLC today ... technology company that will bring low-cost cancer pre-screening tests to primary care physicians ... and automated technology platform detects and measures cellular changes at the nanoscale level. ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... partner for the Academy of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in ... of Tieraona Low Dog, MD, an internationally renowned educator, physician and thought leader ...
(Date:9/3/2015)... Dallas, TX (PRWEB) , ... September 03, 2015 ... ... three pre-conference workshops included in Patient Experience Conference 2016, to be held April ... independent, non-provider or vendor hosted event bringing together the collective voices of healthcare ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... company the final destination of his six-month, 10,000 mile journey from Santiago, Chile ... the trek—which he calls the “Connecting Las Americas” project—Max crossed six countries in ...
(Date:9/3/2015)... ... ... BedJet released a new version of its award winning personal climate control system ... v2 pre-order campaign blazed past the $1 million dollar mark in only 28 ... Kickstarter. , Simple to use and beautifully designed, the award winning BedJet is the ...
Breaking Medicine News(10 mins):Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3
... widely used blood pressure medication may be the key ... according to a newly published study by researchers at ... offer the hope of an improved quality of life ... study drew on a hypothesis from previous studies that ...
... Osaka, Japan, February 13, 2009 Takeda Pharmaceutical Company ... Inc., announced today that the United States Food and ... and 80 mg for the chronic management of hyperuricemia ... the first new treatment option in more than 40 ...
... Foundation (IOF) invites clinicians and researchers in the ... meeting to be held from March 18-21 in ... expected at the four-day meeting which will feature ... broad spectrum of clinically-oriented ,Meet-the-Professor, sessions. The programme ...
... CAFebruary 18, 2009"Suicide by Cop" (SBC) is a suicide method ... to others in an attempt to get oneself killed or ... Journal of Forensic Sciences examined the prevalence of this ... Results show that SBC occurs at extremely high rates, with ...
... the opportunity to be an international leader in personalized ... the health of Canadians and to reap the benefits ... commentary http://www.cmaj.ca/cgi/rapidpdf/cmaj.1090199 released online today in CMAJ ... uses therapies based on an individual,s genetic and health ...
... Is Committed to Providing High Quality Services to ... System, LLC ("Avanti") is pleased to announce that ... Hospital of Gardena ("MHG") and East Los Angeles ... ELADH have been providing quality acute and sub-acute ...
Cached Medicine News:Health News:Blood pressure compound may benefit brain tumor patients 2Health News:Blood pressure compound may benefit brain tumor patients 3Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 2Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 3Health News:'Suicide by cop' phenomenon occurring in over a third of North American shootings involving police 2Health News:Avanti Health System Acquires Two Los Angeles Hospitals 2Health News:Avanti Health System Acquires Two Los Angeles Hospitals 3Health News:Avanti Health System Acquires Two Los Angeles Hospitals 4
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride....
SOC Kit for Bacterial Cells containing 10 x 5mls Sterile growth medium with instructions...
Innovative hemi device combining anatomic design with the advanced material pyrocarbon....
Medicine Products: